nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—Carboplatin—ovarian cancer	0.322	0.484	CbGbCtD
Ticlopidine—CYP2C8—Paclitaxel—ovarian cancer	0.0576	0.0865	CbGbCtD
Ticlopidine—CYP2D6—Vinorelbine—ovarian cancer	0.0523	0.0785	CbGbCtD
Ticlopidine—CYP3A4—Topotecan—ovarian cancer	0.0472	0.0708	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—ovarian cancer	0.041	0.0615	CbGbCtD
Ticlopidine—CYP2C9—Paclitaxel—ovarian cancer	0.0402	0.0603	CbGbCtD
Ticlopidine—CYP3A4—Vinorelbine—ovarian cancer	0.0332	0.0499	CbGbCtD
Ticlopidine—CYP3A4—Paclitaxel—ovarian cancer	0.0234	0.0351	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—ovarian cancer	0.0198	0.0297	CbGbCtD
Ticlopidine—CYP3A4—Docetaxel—ovarian cancer	0.0169	0.0254	CbGbCtD
Ticlopidine—CYP3A4—Doxorubicin—ovarian cancer	0.0126	0.0189	CbGbCtD
Ticlopidine—Clopidogrel—ABCB1—ovarian cancer	0.00225	1	CrCbGaD
Ticlopidine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000946	0.00349	CcSEcCtD
Ticlopidine—Liver function test abnormal—Paclitaxel—ovarian cancer	0.00093	0.00343	CcSEcCtD
Ticlopidine—Anorexia—Chlorambucil—ovarian cancer	0.000921	0.0034	CcSEcCtD
Ticlopidine—Cramp muscle—Paclitaxel—ovarian cancer	0.000907	0.00334	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Epirubicin—ovarian cancer	0.000903	0.00333	CcSEcCtD
Ticlopidine—Arthralgia—Topotecan—ovarian cancer	0.000898	0.00331	CcSEcCtD
Ticlopidine—Myalgia—Topotecan—ovarian cancer	0.000898	0.00331	CcSEcCtD
Ticlopidine—Myalgia—Melphalan—ovarian cancer	0.000879	0.00324	CcSEcCtD
Ticlopidine—Abdominal distension—Paclitaxel—ovarian cancer	0.000876	0.00323	CcSEcCtD
Ticlopidine—Arthropathy—Epirubicin—ovarian cancer	0.000872	0.00322	CcSEcCtD
Ticlopidine—Anaphylactic shock—Topotecan—ovarian cancer	0.00086	0.00317	CcSEcCtD
Ticlopidine—Hyponatraemia—Docetaxel—ovarian cancer	0.000857	0.00316	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000854	0.00315	CcSEcCtD
Ticlopidine—Dyspepsia—Chlorambucil—ovarian cancer	0.000851	0.00314	CcSEcCtD
Ticlopidine—Anaphylactic shock—Melphalan—ovarian cancer	0.000843	0.00311	CcSEcCtD
Ticlopidine—Thrombocytopenia—Topotecan—ovarian cancer	0.000842	0.00311	CcSEcCtD
Ticlopidine—Decreased appetite—Chlorambucil—ovarian cancer	0.00084	0.0031	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.000835	0.00308	CcSEcCtD
Ticlopidine—Pancytopenia—Paclitaxel—ovarian cancer	0.000827	0.00305	CcSEcCtD
Ticlopidine—Pain—Chlorambucil—ovarian cancer	0.000827	0.00305	CcSEcCtD
Ticlopidine—Thrombocytopenia—Melphalan—ovarian cancer	0.000825	0.00304	CcSEcCtD
Ticlopidine—Angioedema—Vinorelbine—ovarian cancer	0.000824	0.00304	CcSEcCtD
Ticlopidine—Anorexia—Topotecan—ovarian cancer	0.00082	0.00302	CcSEcCtD
Ticlopidine—Arthropathy—Doxorubicin—ovarian cancer	0.000807	0.00298	CcSEcCtD
Ticlopidine—Anorexia—Melphalan—ovarian cancer	0.000803	0.00296	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00079	0.00291	CcSEcCtD
Ticlopidine—Liver function test abnormal—Docetaxel—ovarian cancer	0.000788	0.00291	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000784	0.00289	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00077	0.00284	CcSEcCtD
Ticlopidine—Cramp muscle—Docetaxel—ovarian cancer	0.000769	0.00284	CcSEcCtD
Ticlopidine—Urticaria—Chlorambucil—ovarian cancer	0.000768	0.00283	CcSEcCtD
Ticlopidine—Myalgia—Vinorelbine—ovarian cancer	0.000768	0.00283	CcSEcCtD
Ticlopidine—Arthralgia—Vinorelbine—ovarian cancer	0.000768	0.00283	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000768	0.00283	CcSEcCtD
Ticlopidine—Body temperature increased—Chlorambucil—ovarian cancer	0.000764	0.00282	CcSEcCtD
Ticlopidine—Renal failure—Paclitaxel—ovarian cancer	0.000763	0.00281	CcSEcCtD
Ticlopidine—Colitis—Epirubicin—ovarian cancer	0.000762	0.00281	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.000761	0.00281	CcSEcCtD
Ticlopidine—Dyspepsia—Topotecan—ovarian cancer	0.000757	0.00279	CcSEcCtD
Ticlopidine—Decreased appetite—Topotecan—ovarian cancer	0.000748	0.00276	CcSEcCtD
Ticlopidine—Dyspepsia—Melphalan—ovarian cancer	0.000742	0.00273	CcSEcCtD
Ticlopidine—Haematuria—Paclitaxel—ovarian cancer	0.00074	0.00273	CcSEcCtD
Ticlopidine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000736	0.00271	CcSEcCtD
Ticlopidine—Pain—Topotecan—ovarian cancer	0.000736	0.00271	CcSEcCtD
Ticlopidine—Decreased appetite—Melphalan—ovarian cancer	0.000732	0.0027	CcSEcCtD
Ticlopidine—Epistaxis—Paclitaxel—ovarian cancer	0.000732	0.0027	CcSEcCtD
Ticlopidine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000721	0.00266	CcSEcCtD
Ticlopidine—Pain—Melphalan—ovarian cancer	0.00072	0.00266	CcSEcCtD
Ticlopidine—Ecchymosis—Epirubicin—ovarian cancer	0.000717	0.00264	CcSEcCtD
Ticlopidine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000712	0.00263	CcSEcCtD
Ticlopidine—Colitis—Doxorubicin—ovarian cancer	0.000705	0.0026	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000704	0.00259	CcSEcCtD
Ticlopidine—Anorexia—Vinorelbine—ovarian cancer	0.000702	0.00259	CcSEcCtD
Ticlopidine—Pancytopenia—Docetaxel—ovarian cancer	0.000701	0.00258	CcSEcCtD
Ticlopidine—Haemoglobin—Paclitaxel—ovarian cancer	0.0007	0.00258	CcSEcCtD
Ticlopidine—Haemorrhage—Paclitaxel—ovarian cancer	0.000697	0.00257	CcSEcCtD
Ticlopidine—Asthenia—Chlorambucil—ovarian cancer	0.000693	0.00256	CcSEcCtD
Ticlopidine—Sepsis—Epirubicin—ovarian cancer	0.000688	0.00254	CcSEcCtD
Ticlopidine—Pruritus—Chlorambucil—ovarian cancer	0.000684	0.00252	CcSEcCtD
Ticlopidine—Urticaria—Topotecan—ovarian cancer	0.000684	0.00252	CcSEcCtD
Ticlopidine—Body temperature increased—Topotecan—ovarian cancer	0.00068	0.00251	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000671	0.00247	CcSEcCtD
Ticlopidine—Urticaria—Melphalan—ovarian cancer	0.000669	0.00247	CcSEcCtD
Ticlopidine—Ecchymosis—Doxorubicin—ovarian cancer	0.000664	0.00245	CcSEcCtD
Ticlopidine—Diabetes mellitus—Epirubicin—ovarian cancer	0.000662	0.00244	CcSEcCtD
Ticlopidine—Diarrhoea—Chlorambucil—ovarian cancer	0.000661	0.00244	CcSEcCtD
Ticlopidine—Erythema multiforme—Paclitaxel—ovarian cancer	0.000659	0.00243	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000652	0.00241	CcSEcCtD
Ticlopidine—Tinnitus—Paclitaxel—ovarian cancer	0.00065	0.0024	CcSEcCtD
Ticlopidine—Renal failure—Docetaxel—ovarian cancer	0.000647	0.00238	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000645	0.00238	CcSEcCtD
Ticlopidine—Vascular purpura—Epirubicin—ovarian cancer	0.000644	0.00237	CcSEcCtD
Ticlopidine—Hepatic failure—Epirubicin—ovarian cancer	0.000641	0.00236	CcSEcCtD
Ticlopidine—Decreased appetite—Vinorelbine—ovarian cancer	0.00064	0.00236	CcSEcCtD
Ticlopidine—Sepsis—Doxorubicin—ovarian cancer	0.000637	0.00235	CcSEcCtD
Ticlopidine—Hypersensitivity—Topotecan—ovarian cancer	0.000634	0.00234	CcSEcCtD
Ticlopidine—Pain—Vinorelbine—ovarian cancer	0.000629	0.00232	CcSEcCtD
Ticlopidine—Hypersensitivity—Melphalan—ovarian cancer	0.000621	0.00229	CcSEcCtD
Ticlopidine—Epistaxis—Docetaxel—ovarian cancer	0.000621	0.00229	CcSEcCtD
Ticlopidine—Asthenia—Topotecan—ovarian cancer	0.000617	0.00228	CcSEcCtD
Ticlopidine—Vomiting—Chlorambucil—ovarian cancer	0.000615	0.00227	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000613	0.00226	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00061	0.00225	CcSEcCtD
Ticlopidine—Pruritus—Topotecan—ovarian cancer	0.000609	0.00224	CcSEcCtD
Ticlopidine—Asthenia—Melphalan—ovarian cancer	0.000604	0.00223	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000602	0.00222	CcSEcCtD
Ticlopidine—Flatulence—Paclitaxel—ovarian cancer	0.000598	0.0022	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—ovarian cancer	0.000597	0.0022	CcSEcCtD
Ticlopidine—Pruritus—Melphalan—ovarian cancer	0.000596	0.0022	CcSEcCtD
Ticlopidine—Vascular purpura—Doxorubicin—ovarian cancer	0.000596	0.0022	CcSEcCtD
Ticlopidine—Haemoglobin—Docetaxel—ovarian cancer	0.000594	0.00219	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—ovarian cancer	0.000593	0.00219	CcSEcCtD
Ticlopidine—Haemorrhage—Docetaxel—ovarian cancer	0.000591	0.00218	CcSEcCtD
Ticlopidine—Hepatitis—Docetaxel—ovarian cancer	0.000591	0.00218	CcSEcCtD
Ticlopidine—Diarrhoea—Topotecan—ovarian cancer	0.000589	0.00217	CcSEcCtD
Ticlopidine—Urticaria—Vinorelbine—ovarian cancer	0.000585	0.00216	CcSEcCtD
Ticlopidine—Muscle spasms—Paclitaxel—ovarian cancer	0.000583	0.00215	CcSEcCtD
Ticlopidine—Body temperature increased—Vinorelbine—ovarian cancer	0.000582	0.00215	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—ovarian cancer	0.000578	0.00213	CcSEcCtD
Ticlopidine—Diarrhoea—Melphalan—ovarian cancer	0.000576	0.00213	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—ovarian cancer	0.000576	0.00212	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000576	0.00212	CcSEcCtD
Ticlopidine—Nausea—Chlorambucil—ovarian cancer	0.000574	0.00212	CcSEcCtD
Ticlopidine—Dizziness—Topotecan—ovarian cancer	0.000569	0.0021	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000565	0.00208	CcSEcCtD
Ticlopidine—Erythema multiforme—Docetaxel—ovarian cancer	0.000558	0.00206	CcSEcCtD
Ticlopidine—Angioedema—Paclitaxel—ovarian cancer	0.000554	0.00204	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—ovarian cancer	0.000553	0.00204	CcSEcCtD
Ticlopidine—Vomiting—Topotecan—ovarian cancer	0.000547	0.00202	CcSEcCtD
Ticlopidine—Rash—Topotecan—ovarian cancer	0.000543	0.002	CcSEcCtD
Ticlopidine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000542	0.002	CcSEcCtD
Ticlopidine—Dermatitis—Topotecan—ovarian cancer	0.000542	0.002	CcSEcCtD
Ticlopidine—Headache—Topotecan—ovarian cancer	0.000539	0.00199	CcSEcCtD
Ticlopidine—Vomiting—Melphalan—ovarian cancer	0.000536	0.00198	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—ovarian cancer	0.000535	0.00197	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000533	0.00196	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—ovarian cancer	0.000533	0.00196	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—ovarian cancer	0.000532	0.00196	CcSEcCtD
Ticlopidine—Rash—Melphalan—ovarian cancer	0.000531	0.00196	CcSEcCtD
Ticlopidine—Dermatitis—Melphalan—ovarian cancer	0.000531	0.00196	CcSEcCtD
Ticlopidine—Asthenia—Vinorelbine—ovarian cancer	0.000528	0.00195	CcSEcCtD
Ticlopidine—Pruritus—Vinorelbine—ovarian cancer	0.000521	0.00192	CcSEcCtD
Ticlopidine—Arthralgia—Paclitaxel—ovarian cancer	0.000516	0.0019	CcSEcCtD
Ticlopidine—Myalgia—Paclitaxel—ovarian cancer	0.000516	0.0019	CcSEcCtD
Ticlopidine—Nausea—Topotecan—ovarian cancer	0.000511	0.00188	CcSEcCtD
Ticlopidine—Diarrhoea—Vinorelbine—ovarian cancer	0.000504	0.00186	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—ovarian cancer	0.000501	0.00185	CcSEcCtD
Ticlopidine—Nausea—Melphalan—ovarian cancer	0.0005	0.00185	CcSEcCtD
Ticlopidine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000495	0.00183	CcSEcCtD
Ticlopidine—Muscle spasms—Docetaxel—ovarian cancer	0.000494	0.00182	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—ovarian cancer	0.000493	0.00182	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000492	0.00181	CcSEcCtD
Ticlopidine—Dizziness—Vinorelbine—ovarian cancer	0.000487	0.00179	CcSEcCtD
Ticlopidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000485	0.00179	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—ovarian cancer	0.000473	0.00174	CcSEcCtD
Ticlopidine—Anorexia—Paclitaxel—ovarian cancer	0.000472	0.00174	CcSEcCtD
Ticlopidine—Vomiting—Vinorelbine—ovarian cancer	0.000468	0.00173	CcSEcCtD
Ticlopidine—Rash—Vinorelbine—ovarian cancer	0.000464	0.00171	CcSEcCtD
Ticlopidine—Dermatitis—Vinorelbine—ovarian cancer	0.000464	0.00171	CcSEcCtD
Ticlopidine—Abdominal distension—Doxorubicin—ovarian cancer	0.000464	0.00171	CcSEcCtD
Ticlopidine—Headache—Vinorelbine—ovarian cancer	0.000461	0.0017	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—ovarian cancer	0.000456	0.00168	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000451	0.00166	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00044	0.00162	CcSEcCtD
Ticlopidine—Arthralgia—Docetaxel—ovarian cancer	0.000438	0.00161	CcSEcCtD
Ticlopidine—Myalgia—Docetaxel—ovarian cancer	0.000438	0.00161	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—ovarian cancer	0.000437	0.00161	CcSEcCtD
Ticlopidine—Nausea—Vinorelbine—ovarian cancer	0.000437	0.00161	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—ovarian cancer	0.000436	0.00161	CcSEcCtD
Ticlopidine—Dyspepsia—Paclitaxel—ovarian cancer	0.000436	0.00161	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000435	0.0016	CcSEcCtD
Ticlopidine—Decreased appetite—Paclitaxel—ovarian cancer	0.00043	0.00159	CcSEcCtD
Ticlopidine—Pain—Paclitaxel—ovarian cancer	0.000423	0.00156	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—ovarian cancer	0.000423	0.00156	CcSEcCtD
Ticlopidine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00042	0.00155	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—ovarian cancer	0.000419	0.00154	CcSEcCtD
Ticlopidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000411	0.00152	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000407	0.0015	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000405	0.00149	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—ovarian cancer	0.000404	0.00149	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000403	0.00148	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—ovarian cancer	0.0004	0.00148	CcSEcCtD
Ticlopidine—Anorexia—Docetaxel—ovarian cancer	0.0004	0.00148	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—ovarian cancer	0.000398	0.00147	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—ovarian cancer	0.000398	0.00147	CcSEcCtD
Ticlopidine—Urticaria—Paclitaxel—ovarian cancer	0.000393	0.00145	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—ovarian cancer	0.000392	0.00144	CcSEcCtD
Ticlopidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000391	0.00144	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—ovarian cancer	0.000387	0.00143	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000382	0.00141	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—ovarian cancer	0.000377	0.00139	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—ovarian cancer	0.000371	0.00137	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—ovarian cancer	0.00037	0.00137	CcSEcCtD
Ticlopidine—Dyspepsia—Docetaxel—ovarian cancer	0.000369	0.00136	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—ovarian cancer	0.000369	0.00136	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—ovarian cancer	0.000369	0.00136	CcSEcCtD
Ticlopidine—Decreased appetite—Docetaxel—ovarian cancer	0.000365	0.00135	CcSEcCtD
Ticlopidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000365	0.00135	CcSEcCtD
Ticlopidine—Pain—Docetaxel—ovarian cancer	0.000359	0.00132	CcSEcCtD
Ticlopidine—Asthenia—Paclitaxel—ovarian cancer	0.000355	0.00131	CcSEcCtD
Ticlopidine—Pruritus—Paclitaxel—ovarian cancer	0.00035	0.00129	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000349	0.00129	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—ovarian cancer	0.000344	0.00127	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000343	0.00127	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—ovarian cancer	0.000342	0.00126	CcSEcCtD
Ticlopidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000339	0.00125	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—ovarian cancer	0.000333	0.00123	CcSEcCtD
Ticlopidine—Body temperature increased—Docetaxel—ovarian cancer	0.000332	0.00122	CcSEcCtD
Ticlopidine—Dizziness—Paclitaxel—ovarian cancer	0.000327	0.00121	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—ovarian cancer	0.000316	0.00117	CcSEcCtD
Ticlopidine—Vomiting—Paclitaxel—ovarian cancer	0.000315	0.00116	CcSEcCtD
Ticlopidine—Rash—Paclitaxel—ovarian cancer	0.000312	0.00115	CcSEcCtD
Ticlopidine—Dermatitis—Paclitaxel—ovarian cancer	0.000312	0.00115	CcSEcCtD
Ticlopidine—Headache—Paclitaxel—ovarian cancer	0.00031	0.00114	CcSEcCtD
Ticlopidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000309	0.00114	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—ovarian cancer	0.000309	0.00114	CcSEcCtD
Ticlopidine—Asthenia—Docetaxel—ovarian cancer	0.000301	0.00111	CcSEcCtD
Ticlopidine—Pruritus—Docetaxel—ovarian cancer	0.000297	0.00109	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—ovarian cancer	0.000295	0.00109	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—ovarian cancer	0.000295	0.00109	CcSEcCtD
Ticlopidine—Nausea—Paclitaxel—ovarian cancer	0.000294	0.00108	CcSEcCtD
Ticlopidine—Diarrhoea—Docetaxel—ovarian cancer	0.000287	0.00106	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000283	0.00104	CcSEcCtD
Ticlopidine—Dizziness—Docetaxel—ovarian cancer	0.000277	0.00102	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000277	0.00102	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—ovarian cancer	0.000273	0.00101	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—ovarian cancer	0.000273	0.00101	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—ovarian cancer	0.00027	0.000995	CcSEcCtD
Ticlopidine—Vomiting—Docetaxel—ovarian cancer	0.000267	0.000984	CcSEcCtD
Ticlopidine—Rash—Docetaxel—ovarian cancer	0.000265	0.000976	CcSEcCtD
Ticlopidine—Dermatitis—Docetaxel—ovarian cancer	0.000264	0.000975	CcSEcCtD
Ticlopidine—Headache—Docetaxel—ovarian cancer	0.000263	0.000969	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000262	0.000966	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000258	0.000951	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000256	0.000946	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—ovarian cancer	0.00025	0.000921	CcSEcCtD
Ticlopidine—Nausea—Docetaxel—ovarian cancer	0.000249	0.000919	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—ovarian cancer	0.000249	0.000919	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—ovarian cancer	0.000246	0.000907	CcSEcCtD
Ticlopidine—Pain—Epirubicin—ovarian cancer	0.000242	0.000893	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000239	0.00088	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000231	0.000853	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—ovarian cancer	0.000231	0.00085	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—ovarian cancer	0.000228	0.00084	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—ovarian cancer	0.000225	0.000829	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—ovarian cancer	0.000224	0.000826	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—ovarian cancer	0.000224	0.000825	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000214	0.00079	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000209	0.000769	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—ovarian cancer	0.000208	0.000767	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—ovarian cancer	0.000207	0.000763	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—ovarian cancer	0.000203	0.000749	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—ovarian cancer	0.0002	0.000738	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—ovarian cancer	0.000194	0.000714	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000193	0.000712	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—ovarian cancer	0.000188	0.000693	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—ovarian cancer	0.000187	0.00069	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—ovarian cancer	0.000185	0.000683	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—ovarian cancer	0.00018	0.000664	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—ovarian cancer	0.000179	0.000661	CcSEcCtD
Ticlopidine—Rash—Epirubicin—ovarian cancer	0.000178	0.000658	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—ovarian cancer	0.000178	0.000657	CcSEcCtD
Ticlopidine—Headache—Epirubicin—ovarian cancer	0.000177	0.000654	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—ovarian cancer	0.000173	0.000639	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—ovarian cancer	0.000168	0.00062	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—ovarian cancer	0.000167	0.000614	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—ovarian cancer	0.000165	0.000609	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—ovarian cancer	0.000165	0.000608	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—ovarian cancer	0.000164	0.000605	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—ovarian cancer	0.000156	0.000574	CcSEcCtD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CB—ovarian cancer	4.05e-05	0.000671	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—HRAS—ovarian cancer	3.98e-05	0.000659	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYTB—ovarian cancer	3.93e-05	0.000652	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NME2—ovarian cancer	3.89e-05	0.000645	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CXCL8—ovarian cancer	3.89e-05	0.000645	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.87e-05	0.000641	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.86e-05	0.00064	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.85e-05	0.000637	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	3.72e-05	0.000617	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—BRIP1—ovarian cancer	3.72e-05	0.000617	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL2—ovarian cancer	3.72e-05	0.000616	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TERT—ovarian cancer	3.7e-05	0.000614	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—BRIP1—ovarian cancer	3.65e-05	0.000604	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPP1CC—ovarian cancer	3.65e-05	0.000604	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYTB—ovarian cancer	3.61e-05	0.000598	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.53e-05	0.000584	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—AKT1—ovarian cancer	3.51e-05	0.000582	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.45e-05	0.000572	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—BRIP1—ovarian cancer	3.44e-05	0.00057	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPP1CC—ovarian cancer	3.44e-05	0.00057	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CAV1—ovarian cancer	3.43e-05	0.000568	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ESR1—ovarian cancer	3.3e-05	0.000547	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.3e-05	0.000547	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6ST—ovarian cancer	3.25e-05	0.000538	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYTB—ovarian cancer	3.22e-05	0.000533	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPP1CC—ovarian cancer	3.15e-05	0.000522	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—BRIP1—ovarian cancer	3.15e-05	0.000522	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.15e-05	0.000522	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.15e-05	0.000521	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CG—ovarian cancer	3.12e-05	0.000517	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—APC—ovarian cancer	3.12e-05	0.000517	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—NRAS—ovarian cancer	3.12e-05	0.000517	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NME2—ovarian cancer	3e-05	0.000498	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—MAPK3—ovarian cancer	2.99e-05	0.000495	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYTB—ovarian cancer	2.96e-05	0.000491	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYTB—ovarian cancer	2.94e-05	0.000486	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.87e-05	0.000475	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—MAPK1—ovarian cancer	2.84e-05	0.000471	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—EGFR—ovarian cancer	2.84e-05	0.000471	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.81e-05	0.000466	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.81e-05	0.000466	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CD—ovarian cancer	2.74e-05	0.000455	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—PIK3CA—ovarian cancer	2.72e-05	0.00045	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.69e-05	0.000446	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—KRAS—ovarian cancer	2.69e-05	0.000445	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	2.59e-05	0.000429	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—BRIP1—ovarian cancer	2.59e-05	0.000429	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—BRIP1—ovarian cancer	2.57e-05	0.000425	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPP1CC—ovarian cancer	2.57e-05	0.000425	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYTB—ovarian cancer	2.51e-05	0.000416	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.51e-05	0.000415	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—YAP1—ovarian cancer	2.5e-05	0.000414	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CA—ovarian cancer	2.47e-05	0.000409	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.45e-05	0.000406	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—YAP1—ovarian cancer	2.45e-05	0.000405	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ERBB2—ovarian cancer	2.42e-05	0.000402	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CB—ovarian cancer	2.39e-05	0.000396	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MTOR—ovarian cancer	2.39e-05	0.000396	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—YAP1—ovarian cancer	2.31e-05	0.000382	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCL8—ovarian cancer	2.3e-05	0.000381	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.3e-05	0.000381	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HRAS—ovarian cancer	2.28e-05	0.000378	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.28e-05	0.000378	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CDKN1B—ovarian cancer	2.24e-05	0.000372	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—AKT1—ovarian cancer	2.22e-05	0.000368	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CASP3—ovarian cancer	2.2e-05	0.000364	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL2—ovarian cancer	2.2e-05	0.000364	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	2.19e-05	0.000363	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—BRIP1—ovarian cancer	2.19e-05	0.000363	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL6—ovarian cancer	2.19e-05	0.000362	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCND1—ovarian cancer	2.14e-05	0.000355	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CTNNB1—ovarian cancer	2.12e-05	0.000351	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—YAP1—ovarian cancer	2.11e-05	0.00035	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.09e-05	0.000347	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MMP9—ovarian cancer	2.08e-05	0.000344	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTEN—ovarian cancer	2.07e-05	0.000342	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.05e-05	0.00034	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—FASN—ovarian cancer	2.04e-05	0.000337	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—AKT1—ovarian cancer	2.02e-05	0.000334	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.01e-05	0.000332	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	2e-05	0.000332	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—FASN—ovarian cancer	1.99e-05	0.00033	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.96e-05	0.000325	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYTB—ovarian cancer	1.94e-05	0.000321	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.93e-05	0.00032	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.89e-05	0.000314	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—YAP1—ovarian cancer	1.89e-05	0.000313	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—FASN—ovarian cancer	1.88e-05	0.000312	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.87e-05	0.00031	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.87e-05	0.000309	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—ovarian cancer	1.87e-05	0.000309	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.85e-05	0.000307	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—SLC5A5—ovarian cancer	1.85e-05	0.000306	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—ovarian cancer	1.85e-05	0.000306	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NRAS—ovarian cancer	1.84e-05	0.000306	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.84e-05	0.000305	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.82e-05	0.000301	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—SLC2A1—ovarian cancer	1.79e-05	0.000296	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK3—ovarian cancer	1.77e-05	0.000293	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.75e-05	0.00029	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—YAP1—ovarian cancer	1.74e-05	0.000288	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—FASN—ovarian cancer	1.72e-05	0.000286	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—YAP1—ovarian cancer	1.72e-05	0.000285	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—ovarian cancer	1.72e-05	0.000285	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP1B1—ovarian cancer	1.71e-05	0.000284	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.7e-05	0.000282	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.7e-05	0.000281	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.69e-05	0.00028	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.69e-05	0.00028	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK1—ovarian cancer	1.68e-05	0.000278	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGFR—ovarian cancer	1.68e-05	0.000278	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.64e-05	0.000272	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.64e-05	0.000272	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.64e-05	0.000271	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.61e-05	0.000267	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.6e-05	0.000266	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.6e-05	0.000265	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KRAS—ovarian cancer	1.59e-05	0.000263	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.57e-05	0.00026	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—FASN—ovarian cancer	1.54e-05	0.000255	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.53e-05	0.000253	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	1.52e-05	0.000252	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.51e-05	0.000251	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.51e-05	0.00025	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—TYMS—ovarian cancer	1.5e-05	0.000248	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.5e-05	0.000248	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.5e-05	0.000248	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—YAP1—ovarian cancer	1.47e-05	0.000244	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—TYMS—ovarian cancer	1.47e-05	0.000243	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.46e-05	0.000242	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—ovarian cancer	1.46e-05	0.000242	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.46e-05	0.000241	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.43e-05	0.000237	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—FASN—ovarian cancer	1.42e-05	0.000234	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—ovarian cancer	1.41e-05	0.000234	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ABCB1—ovarian cancer	1.41e-05	0.000234	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—FASN—ovarian cancer	1.4e-05	0.000232	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.4e-05	0.000232	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.39e-05	0.000231	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1.39e-05	0.000231	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.39e-05	0.00023	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—TYMS—ovarian cancer	1.38e-05	0.000229	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.38e-05	0.000229	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—ovarian cancer	1.35e-05	0.000224	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	1.34e-05	0.000223	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.33e-05	0.000221	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.31e-05	0.000216	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.29e-05	0.000214	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—ovarian cancer	1.29e-05	0.000214	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.29e-05	0.000214	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.28e-05	0.000212	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.28e-05	0.000212	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMS—ovarian cancer	1.27e-05	0.00021	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.24e-05	0.000206	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.24e-05	0.000205	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CAV1—ovarian cancer	1.21e-05	0.0002	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—FASN—ovarian cancer	1.2e-05	0.000199	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—ovarian cancer	1.19e-05	0.000197	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CAV1—ovarian cancer	1.18e-05	0.000196	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.18e-05	0.000195	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.15e-05	0.000191	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.14e-05	0.000189	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.14e-05	0.000189	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—YAP1—ovarian cancer	1.13e-05	0.000188	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMS—ovarian cancer	1.13e-05	0.000188	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.13e-05	0.000188	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.13e-05	0.000187	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CAV1—ovarian cancer	1.12e-05	0.000185	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.12e-05	0.000185	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.1e-05	0.000182	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.09e-05	0.000181	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	1.08e-05	0.000179	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.07e-05	0.000177	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.06e-05	0.000176	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.05e-05	0.000174	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMS—ovarian cancer	1.04e-05	0.000173	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMS—ovarian cancer	1.03e-05	0.000171	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CAV1—ovarian cancer	1.02e-05	0.00017	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—ovarian cancer	1.02e-05	0.000168	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.77e-06	0.000162	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	9.68e-06	0.00016	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	9.68e-06	0.00016	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.64e-06	0.00016	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	9.48e-06	0.000157	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	9.32e-06	0.000154	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—FASN—ovarian cancer	9.25e-06	0.000153	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CAV1—ovarian cancer	9.13e-06	0.000151	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	9.1e-06	0.000151	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ABCB1—ovarian cancer	8.99e-06	0.000149	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CD—ovarian cancer	8.94e-06	0.000148	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMS—ovarian cancer	8.83e-06	0.000146	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	8.79e-06	0.000146	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.72e-06	0.000145	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	8.43e-06	0.00014	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	8.43e-06	0.00014	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CAV1—ovarian cancer	8.4e-06	0.000139	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CAV1—ovarian cancer	8.33e-06	0.000138	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	8.32e-06	0.000138	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	8.26e-06	0.000137	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	8.19e-06	0.000136	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.96e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	7.79e-06	0.000129	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	7.65e-06	0.000127	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	7.58e-06	0.000126	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	7.47e-06	0.000124	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	7.31e-06	0.000121	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—ovarian cancer	7.29e-06	0.000121	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	7.14e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—ovarian cancer	7.14e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CAV1—ovarian cancer	7.12e-06	0.000118	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.94e-06	0.000115	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMS—ovarian cancer	6.82e-06	0.000113	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.8e-06	0.000113	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—ovarian cancer	6.73e-06	0.000112	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	6.73e-06	0.000111	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	6.67e-06	0.00011	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	6.48e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	6.37e-06	0.000106	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—ovarian cancer	6.17e-06	0.000102	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	5.86e-06	9.71e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	5.81e-06	9.63e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	5.7e-06	9.44e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—ovarian cancer	5.51e-06	9.13e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CAV1—ovarian cancer	5.49e-06	9.1e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	5.14e-06	8.52e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—ovarian cancer	5.07e-06	8.39e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	5.04e-06	8.34e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—ovarian cancer	5.02e-06	8.32e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5e-06	8.29e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	4.97e-06	8.23e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	4.75e-06	7.87e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.4e-06	7.29e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	4.35e-06	7.21e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—ovarian cancer	4.29e-06	7.11e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—ovarian cancer	4.2e-06	6.96e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—ovarian cancer	4.11e-06	6.82e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	3.89e-06	6.44e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—ovarian cancer	3.88e-06	6.43e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.83e-06	6.35e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	3.57e-06	5.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—ovarian cancer	3.56e-06	5.89e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	3.54e-06	5.87e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—ovarian cancer	3.31e-06	5.49e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—ovarian cancer	3.17e-06	5.26e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.03e-06	5.02e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—ovarian cancer	2.92e-06	4.84e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—ovarian cancer	2.89e-06	4.8e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—ovarian cancer	2.47e-06	4.1e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.34e-06	3.87e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.91e-06	3.16e-05	CbGpPWpGaD
